• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Device Problem Fracture (1260)
Patient Problem Surgical procedure, additional (2564)
Event Type  Injury  
Event Description
The patient is a (b)(6) male, diabetic but healthy/active and complaint, taking a regular dose of plavix.The procedure for stent placement was performed (b)(6) 2013 based on claudication.His right leg was treated with a zilver ptx stent.The physician said that the patient's stent had fractured.Re-intervention was performed on the right side and the doctor will also perform a bypass in the next month or two.No further adverse effects to the patient have been reported as a result of this specific occurrence.The info received indicated the patient is doing well.
 
Manufacturer Narrative
Udi#: unk.The specific rpn of the device involved in this complaint is unk.The info provided indicated the device to be a zilver ptx.The device involved in this complaint remains implanted in the patient; therefore, will not be returned to cook ireland for evaluation.With the info provided a document based investigation was carried out.To data images have not been reviewed relating to this event.The customer complaint could be confirmed based on customer testimony.Zilver ptx drug eluting stent is the component involved in this complaint and undergoes inspection.A review of the relevant manufacturing records for zilver ptx and zilver ptx drug eluting stents could not be performed as the lot number of the complaint device was not provided.As per instructions for use ifu0093-4, it may be noted that stent fracture is a potential adverse event associated with the placement of this device.Prior to distribution all zilver ptx devices are subjected to visual inspection and functional checks to ensure device integrity.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
limerick
EI 
Manufacturer Contact
sinead quaid, senior specialist
61334440
MDR Report Key4283403
MDR Text Key5299174
Report Number3001845648-2014-00244
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100022/S001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/22/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location Hospital
Date Manufacturer Received10/24/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-